- Home
- CIX vs ATAI Comparison
CIX vs ATAI Comparison
Compare CIX & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIX
- ATAI
- Stock Information
- Founded
- CIX 1993
- ATAI 2018
- Country
- CIX United States
- ATAI Germany
- Employees
- CIX N/A
- ATAI N/A
- Industry
- CIX Industrial Machinery/Components
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- CIX Consumer Discretionary
- ATAI Health Care
- Exchange
- CIX Nasdaq
- ATAI Nasdaq
- Market Cap
- CIX 301.8M
- ATAI 444.7M
- IPO Year
- CIX 1998
- ATAI 2021
- Fundamental
- Price
- CIX $27.92
- ATAI $2.22
- Analyst Decision
- CIX
- ATAI Strong Buy
- Analyst Count
- CIX 0
- ATAI 3
- Target Price
- CIX N/A
- ATAI $10.50
- AVG Volume (30 Days)
- CIX 3.7K
- ATAI 2.7M
- Earning Date
- CIX 08-05-2025
- ATAI 08-12-2025
- Dividend Yield
- CIX 4.43%
- ATAI N/A
- EPS Growth
- CIX N/A
- ATAI N/A
- EPS
- CIX 1.46
- ATAI N/A
- Revenue
- CIX $148,242,000.00
- ATAI $1,863,000.00
- Revenue This Year
- CIX N/A
- ATAI $554.22
- Revenue Next Year
- CIX N/A
- ATAI N/A
- P/E Ratio
- CIX $18.58
- ATAI N/A
- Revenue Growth
- CIX N/A
- ATAI 572.56
- 52 Week Low
- CIX $17.89
- ATAI $1.03
- 52 Week High
- CIX $36.10
- ATAI $2.64
- Technical
- Relative Strength Index (RSI)
- CIX 51.96
- ATAI 53.76
- Support Level
- CIX $22.81
- ATAI $2.06
- Resistance Level
- CIX $26.29
- ATAI $2.51
- Average True Range (ATR)
- CIX 0.75
- ATAI 0.17
- MACD
- CIX 0.14
- ATAI -0.03
- Stochastic Oscillator
- CIX 62.93
- ATAI 46.08
About CIX CompX International Inc.
Compx International Inc is a manufacturer of security products. Its security products are used in recreational transportation, postal, office & institutional furniture, cabinetry, tool storage, healthcare, and a variety of other industries. Also, it is engaged in the manufacturing of stainless steel exhaust systems, gauges, throttle controls, and trim tabs for the recreational marine industry. The company's operating segment includes Security Products and Marine Components. The company generates maximum revenue from the Security Products segment, which manufactures mechanical and electrical cabinet locks and other locking mechanisms. Its geographical segments are the United States, Canada, Mexico, and others, of which the United States accounts for the vast majority of revenue.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.